Publication

Ohadi M, Shirazi E, Tehranidoost M, Moghimi N, Keikhaee M, Ehsani S, Aghajani A. 2006. Attention-deficit/hyperactivity disorder (ADHD) association with the DAT1 core promoter-67 allele. Brain Res. 2006 Jul 26; 1101(1): 1-4.

Brennan P, Hsu CC, Moullan N, Szeszenia-Dabrowska N, Lissowska J, Zaridze D, Rudnai P, Fabianova E, Mates D, Bencko V, et al. 2005. Effect of cruciferous vegetables on lung cancer in patients stratified by genetic status: a mendelian randomisation approach. Lancet. 366:1558–60. doi:10.1016/S0140-6736(05)67628-3.

Li R, Chase M, Jung S-K, Smith PJS, Loeken MR. 2005. Hypoxic stress in diabetic pregnancy contributes to impaired embryo gene expression and defective development by inducing oxidative stress. Am J Physiol Endocrinol Metab. 289:E591–9. doi:10.1152/ajpendo.00441.2004.

Bolger TA, Yao T-P. 2005. Intracellular trafficking of histone deacetylase 4 regulates neuronal cell death. J Neurosci. 25:9544–53. doi:10.1523/JNEUROSCI.1826-05.2005.

Liu Z, Stevenson GD, Barrett HH, Furenlid LR, Wilson DW, Kastis GA, Bettan M, Woolfenden JM. 2005. Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin. Nucl Med Biol. 32:573–83. doi:10.1016/j.nucmedbio.2005.04.014.

Hsu CC, Kao WHL, Coresh J, Pankow JS, Marsh-Manzi J, Boerwinkle E, Bray MS. 2005. Apolipoprotein E and progression of chronic kidney disease. JAMA. 293:2892–9. doi:10.1001/jama.293.23.2892.

Landowski TH, Megli CJ, Nullmeyer KD, Lynch RM, Dorr RT. 2005. Mitochondrial-mediated disregulation of Ca2+ is a critical determinant of Velcade (PS-341/bortezomib) cytotoxicity in myeloma cell lines. Cancer Res. 65:3828–36. doi:10.1158/0008-5472.CAN-04-3684.

Bair EL, Chen ML, McDaniel K, Sekiguchi K, Cress AE, Nagle RB, Bowden GT. 2005. Membrane type 1 matrix metalloprotease cleaves laminin-10 and promotes prostate cancer cell migration. Neoplasia. 7:380–9. doi:10.1593/neo.04619.

Ibrahim MM, Porreca F, Lai J, Albrecht PJ, Rice FL, Khodorova A, Davar G, Makriyannis A, Vanderah TW, Mata HP, et al. 2005. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Sci U S A. 102:3093–8. doi:10.1073/pnas.0409888102.

Weichsel A, Maes EM, Andersen JF, Valenzuela JG, Shokhireva TK, Walker FA, Montfort WR. 2005. Heme-assisted S-nitrosation of a proximal thiolate in a nitric oxide transport protein. Proc Natl Acad Sci U S A. 102:594–9. doi:10.1073/pnas.0406549102.

Liu Z, Barrett HH, Stevenson GD, Kastis GA, Bettan M, Furenlid LR, Wilson DW, Pak KY. 2004. High-resolution imaging with (99m)Tc-glucarate for assessing myocardial injury in rat heart models exposed to different durations of ischemia with reperfusion. J Nucl Med. 45:1251–9.

Go VLW, Wong DA, Wang Y, Butrum RR, Norman HA, Wilkerson L. 2004. Diet and cancer prevention: evidence-based medicine to genomic medicine. J Nutr. 134:3513S-3516S. doi:10.1093/jn/134.12.3513S.

Ibrahim MM, Deng H, Zvonok A, Cockayne DA, Kwan J, Mata HP, Vanderah TW, Lai J, Porreca F, Makriyannis A, et al. 2003. Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc Natl Acad Sci U S A. 100:10529–33. doi:10.1073/pnas.1834309100.

Zhu Y, Hua P, Lance P. 2003. Cyclooxygenase-2 expression and prostanoid biogenesis reflect clinical phenotype in human colorectal fibroblast strains. Cancer Res. 63:522–6.

Hruby VJ. 2002. Designing peptide receptor agonists and antagonists. Nat Rev Drug Discov. 1:847–58. doi:10.1038/nrd939.

Bair EL, Massey CP, Tran NL, Borchers AH, Heimark RL, Cress AE, Bowden GT. 2001. Integrin- and cadherin-mediated induction of the matrix metalloprotease matrilysin in cocultures of malignant oral squamous cell carcinoma cells and dermal fibroblasts. Exp Cell Res. 270:259–67. doi:10.1006/excr.2001.5347.

Ryder NM, Guha S, Hines OJ, Reber HA, Rozengurt E. 2001. G protein-coupled receptor signaling in human ductal pancreatic cancer cells: neurotensin responsiveness and mitogenic stimulation. J Cell Physiol. 186:53–64. doi:10.1002/1097-4652(200101)186:1<53::AID-JCP1004>3.0.CO;2-Q.

Akbarian M, Shahnia S, Ehsani S, Shahram F, Davatchi F. 2001. Infection in Systemic lupus erythematosus (SLE), a 21 year study. Annals of the Rheumatic Diseases, July 2001, Vol 60, supplement 1, page 72.

Vanderah TW, Suenaga NM, Ossipov MH, Malan TP, Lai J, Porreca F. 2001. Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J Neurosci. 21:279–86.

Suryanarayanan S, Karellas A, Vedantham S, Glick SJ, D’Orsi CJ, Baker SP, Webber RL. 2000. Comparison of tomosynthesis methods used with digital mammography. Acad Radiol. 7:1085–97. doi:10.1016/s1076-6332(00)80061-6.

Vanderah TW, Gardell LR, Burgess SE, Ibrahim M, Dogrul A, Zhong CM, Zhang ET, Malan TP, Ossipov MH, Lai J, et al. 2000. Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J Neurosci. 20:7074–9.

Weichsel A, Andersen JF, Roberts SA, Montfort WR. 2000. Nitric oxide binding to nitrophorin 4 induces complete distal pocket burial. Nat Struct Biol. 7:551–4. doi:10.1038/76769.

Vedantham S, Karellas A, Suryanarayanan S, Albagli D, Han S, Tkaczyk EJ, Landberg CE, Opsahl-Ong B, Granfors PR, Levis I, et al. 2000. Full breast digital mammography with an amorphous silicon-based flat panel detector: physical characteristics of a clinical prototype. Med Phys. 27:558–67. doi:10.1118/1.598895.

Brown CB, Boyer AS, Runyan RB, Barnett JV. 1999. Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart. Science. 283:2080–2.

Dyall R, Vasović LV, Clynes RA, Nikolić-Zugic J. 1999. Cellular requirements for the monoclonal antibody-mediated eradication of an established solid tumor. Eur J Immunol. 29:30–7. doi:10.1002/(SICI)1521-4141(199901)29:01<30::AID-IMMU30>3.0.CO;2-D.